Brief: Bausch Health Provides Update On RED-C Phase 3 Clinical Trials
23/01/2026 12:48
Jan 23 (Reuters) - Bausch Health Companies Inc BHC.TO: BAUSCH HEALTH PROVIDES UPDATE ON RED-C PHASE 3 CLINICAL TRIALS BAUSCH HEALTH COMPANIES INC - PHASE 3 TRIALS DID NOT MEET PRIMARY ENDPOINT Source text: ID:nCNWFGCR8a Further company coverage: BHC.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: Bausch Health Companies -Co And Yun Expand Strategic Collaboration In Mexico And EMEA Markets
Canada Stocks: Toronto stocks near record high as investors weigh earnings, US PPI data